Your browser doesn't support javascript.
loading
Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan.
Izumo, Takehiro; Kuse, Naoyuki; Awano, Nobuyasu; Tone, Mari; Sakamoto, Keita; Takada, Kohei; Muto, Yutaka; Fujimoto, Kazushi; Saiki, Ayae; Ito, Yu; Matsumoto, Haruko; Inomata, Minoru.
Afiliación
  • Izumo T; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan. Electronic address: izumo_takehiro@med.jrc.or.jp.
  • Kuse N; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Awano N; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Tone M; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Sakamoto K; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Takada K; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Muto Y; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Fujimoto K; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Saiki A; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Ito Y; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Matsumoto H; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Inomata M; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
Respir Investig ; 59(5): 635-642, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34210623

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Respir Investig Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Respir Investig Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos